Cynthia Jane Campen, MD
Neurology With Special Qualifications in Child Neurology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Campen’s office at (650) 497-8000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A107269 · Current
Licensed to practise in California · since 2009 · expires 2028-08-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$2,707 in 2024
Medicaid paid $2,707 for 17 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 17 | $2,707 |
| 2024 | 17 | 1 | 14 | $2,707 |
| 2023 | 106 | 1 | 20 | $13,622 |
| 2021 | 12 | 1 | 12 | $1,702 |
| 2020 | 15 | 1 | 13 | $1,277 |
| 2018 | 45 | 2 | 14 | $3,833 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 106 | $13,622 |
2021
| Long return visit (40+ min) | 12 | $1,702 |
2020
| Return visit (30+ min) | 15 | $1,277 |
2018
| Long return visit (40+ min) | 33 | $2,940 |
| Return visit (30+ min) | 12 | $893 |
Money from drug and device companies
$143 in 2025
| 2025 | 2 | 2 | None | $143 |
| 2023 | 1 | 1 | $1,280 | $1,280 |
| 2022 | 1 | 1 | $2,240 | $2,240 |
| 2021 | 1 | 3 | $4,848 | $4,848 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Day One Biopharmaceuticals | Ojemda | $119 | 1 payment
|
| Alexion Pharmaceuticals | None | $24 | 1 payment
|
See all 2 published payments
| Day One Biopharmaceuticals | Meals · 2025-07-31 | Ojemda | $119 |
| Alexion Pharmaceuticals | Meals · 2025-06-21 | None | $24 |
See earlier years (2023, 2022, 2021)
2023: $1,280
| Alexion Pharmaceuticals | None | $1,280 | 1 payment
|
2022: $2,240
| Alexion Pharmaceuticals | Koselugo | $2,240 | 1 payment
|
2021: $4,848
| AstraZeneca Pharmaceuticals LP | Koselugo | $4,848 | 3 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| SpringWorks Therapeutics, Inc. · Mek-Nf-201 · 2025 | Their institution | $50,148 |
| SpringWorks Therapeutics, Inc. · Mek-Nf-201 · 2024 | Their institution | $24,485 |
| Alexion Pharmaceuticals, Inc. · This Is A US Observational Registry of Pediatric Nf1 Pn Participants Treated With Selumetinib. · 2025 | Their institution | $11,500 |
Professional record
- NPI
- 1447315791
- Licence
- CA A 107269California A107269: Current · expires 2028-08-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084N0402X (2084N0402X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2006-12-27
- NPI last updated
- 2023-11-09
- NPI record certified
- 2023-11-09
This is when the NPI record was last certified, not a medical board exam.